These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12106782)

  • 1. CpG DNA: recognition by and activation of monocytes.
    Klinman DM; Takeshita F; Gursel I; Leifer C; Ishii KJ; Verthelyi D; Gursel M
    Microbes Infect; 2002 Jul; 4(9):897-901. PubMed ID: 12106782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
    Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
    Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CpG oligodeoxynucleotides as immunoprotective agents.
    Klinman DM
    Expert Opin Biol Ther; 2004 Jun; 4(6):937-46. PubMed ID: 15174975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
    Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
    J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
    Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
    Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-oligonucleotides in vaccination: signaling and mechanisms of action.
    Dalpke A; Zimmermann S; Heeg K
    Immunobiology; 2001 Dec; 204(5):667-76. PubMed ID: 11846232
    [No Abstract]   [Full Text] [Related]  

  • 7. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.
    Hoene V; Peiser M; Wanner R
    J Leukoc Biol; 2006 Dec; 80(6):1328-36. PubMed ID: 17000899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
    Vollmer J; Jurk M; Samulowitz U; Lipford G; Forsbach A; Wüllner M; Tluk S; Hartmann H; Kritzler A; Müller C; Schetter C; Krieg AM
    J Endotoxin Res; 2004; 10(6):431-8. PubMed ID: 15588427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical recognition of CpG motifs expressed by immunostimulatory oligodeoxynucleotides.
    Klinman DM; Currie D
    Clin Exp Immunol; 2003 Aug; 133(2):227-32. PubMed ID: 12869028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
    Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
    J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides.
    Lenert P; Goeken A; Handwerger BS; Ashman RF
    J Clin Immunol; 2003 May; 23(3):202-13. PubMed ID: 12797542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-DNA as immune response modifier.
    Dalpke AH; Heeg K
    Int J Med Microbiol; 2004 Oct; 294(5):345-54. PubMed ID: 15532993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity.
    Wagner H
    Curr Opin Microbiol; 2002 Feb; 5(1):62-9. PubMed ID: 11834371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88.
    Schnare M; Holt AC; Takeda K; Akira S; Medzhitov R
    Curr Biol; 2000 Sep; 10(18):1139-42. PubMed ID: 10996797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.
    Kadowaki N; Ho S; Antonenko S; Malefyt RW; Kastelein RA; Bazan F; Liu YJ
    J Exp Med; 2001 Sep; 194(6):863-9. PubMed ID: 11561001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D
    Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.